Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy



Status:Not yet recruiting
Healthy:No
Age Range:18 - Any
Updated:1/2/2019
Start Date:March 15, 2019
End Date:June 15, 2021

Use our guide to learn which trials are right for you!

Holographic Mm-wave Imaging in Radiation Oncology

This trial studies the quality of holographic mm-wave imaging in patients undergoing
radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport
body scanners that may be helpful in improving the efficiency and positioning of radiation
oncology patients and their overall experience.

PRIMARY OBJECTIVES:

I. To obtain patient images in a clinical setting and assess their quality.

SECONDARY OBJECTIVES:

I. To assess the registration agreement through a voxel-voxel distance-to-agreement metric.

OUTLINE:

Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial
computed tomography (CT) simulation.

Inclusion Criteria:

- Patients who are scheduled to receive either an optical or CBCT imaging scan as part
of their treatment management.

- The study will be open to English and Spanish speaking participants.

Exclusion Criteria:

- Patients that are not scheduled for fluoroscopic or optical imaging as part of the
normal course of radiotherapy.
We found this trial at
1
site
1441 Eastlake Ave
Los Angeles, California 90033
(323) 865-3000
Principal Investigator: Michael Reilly
Phone: 708-951-1100
U.S.C./Norris Comprehensive Cancer Center The USC Norris Comprehensive Cancer Center, located in Los Angeles, is...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials